Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment-Reference-Cited by-同舟云学术

Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment

Published:2011-10-13 Issue:10 Volume:6 Page:e25482
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kaddurah-Daouk Rima,Baillie Rebecca A.,Zhu Hongjie,Zeng Zhao-Bang,Wiest Michelle M.,Nguyen Uyen Thao,Wojnoonski Katie,Watkins Steven M.,Trupp Miles,Krauss Ronald M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.;Z Zhou;Am Heart J,2006

2. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.;PM Ridker;N Engl J Med,2008

3. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.;C Baigent;Lancet,2005

4. The JUPITER trial: results, controversies, and implications for prevention.;PM Ridker;Circ Cardiovasc Qual Outcomes,2009

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling gut microbiota's role: Bidirectional regulation of drug transport for improved safety;Medicinal Research Reviews;2024-08-24

2. Role of gut microbiota and metabolomics in the lipid-lowering efficacy of statins among Chinese patients with coronary heart disease and hypercholesterolemia;Frontiers in Cellular and Infection Microbiology;2024-07-25

3. Microbiome and pancreatic cancer: time to think about chemotherapy;Gut Microbes;2024-07-18

4. Association between Fecal Bile Acids and Levodopa Response in Patients with Parkinson’s Disease;Microorganisms;2024-07-15

5. Therapeutic manipulation of the microbiome in liver disease;Hepatology;2024-06-26